新諾威(300765.SZ):董事王輝違規減持2725股
格隆匯4月4日丨新諾威(300765.SZ)公佈,董事王輝因誤操作個人證券賬户,在未披露股份減持計劃的情況下,於2023年4月3日通過集中競價交易方式賣出公司股份2725股,違反了《深圳證券交易所上市公司股東及董事、監事、高級管理人員減持股份實施細則》等相關規定。
王輝在發現上述誤操作之後,積極向公司説明情況,並配合公司進行處理。經公司核查,王輝本次減持股份不處於窗口期,也未構成短線交易,也不存在利用內幕信息交易獲利的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.